In 2009, Tecchio et al. [24] documented successful clinical outcome of a previously untreated B-CLL patient (trisomy 12 positive, IgVH mutated, and ZAP-70 negative) who experienced CML nine years after. The gene discussed is ZAP70; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.